|
US20160000902A1
(en)
*
|
2003-07-11 |
2016-01-07 |
Novavax, Inc. |
Combination vaccine for respiratory syncytial virus and influenza
|
|
DK2347775T3
(da)
|
2005-12-13 |
2020-07-13 |
Harvard College |
Skabeloner til celletransplantation
|
|
US9770535B2
(en)
|
2007-06-21 |
2017-09-26 |
President And Fellows Of Harvard College |
Scaffolds for cell collection or elimination
|
|
KR101617895B1
(ko)
|
2007-12-24 |
2016-05-03 |
글락소스미스클라인 바이오로지칼즈 에스.에이. |
재조합 ｒｓｖ 항원
|
|
CN102006891B
(zh)
|
2008-02-13 |
2017-04-26 |
哈佛学院董事会 |
连续的细胞程序化装置
|
|
US9370558B2
(en)
|
2008-02-13 |
2016-06-21 |
President And Fellows Of Harvard College |
Controlled delivery of TLR agonists in structural polymeric devices
|
|
US11446374B2
(en)
|
2008-12-09 |
2022-09-20 |
Novavax, Inc. |
Modified RSV F proteins and methods of their use
|
|
KR101691574B1
(ko)
|
2008-12-09 |
2017-01-02 |
노바백스, 인코포레이티드 |
변형 ｒｓｖ ｆ 단백질 및 이들의 사용 방법
|
|
DK2445526T3
(en)
|
2009-06-24 |
2016-06-27 |
Glaxosmithkline Biologicals Sa |
Recombinant RSV antigens.
|
|
MX2012000036A
(es)
*
|
2009-06-24 |
2012-02-28 |
Glaxosmithkline Biolog Sa |
Vacuna.
|
|
TW201116294A
(en)
|
2009-07-15 |
2011-05-16 |
Novartis Ag |
RSV F protein compositions and methods for making same
|
|
CN103977394B
(zh)
*
|
2009-07-17 |
2016-03-09 |
翰林大学校产学协力团 |
包含脂质体包胶的寡核苷酸和表位的免疫刺激性组合物
|
|
US8728456B2
(en)
|
2009-07-31 |
2014-05-20 |
President And Fellows Of Harvard College |
Programming of cells for tolerogenic therapies
|
|
CA2770304C
(en)
*
|
2009-08-04 |
2019-11-26 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services, Centers For Disease Control And Prevention |
Anti-rsv immunogens and methods of immunization
|
|
CA2799934C
(en)
|
2010-07-07 |
2020-01-28 |
Artificial Cell Technologies, Inc. |
Respiratory syncytial virus antigenic compositions and methods
|
|
EP3620185A1
(en)
|
2010-10-06 |
2020-03-11 |
President and Fellows of Harvard College |
Injectable, pore-forming hydrogels for materials-based cell therapies
|
|
WO2012103496A2
(en)
*
|
2011-01-28 |
2012-08-02 |
Medimmune, Llc |
Expression of soluble viral fusion glycoproteins in mammalian cells
|
|
EP2701734B1
(en)
*
|
2011-04-26 |
2019-09-25 |
Molecular Express, Inc. |
Liposomal formulations
|
|
ES2685327T3
(es)
|
2011-04-28 |
2018-10-08 |
President And Fellows Of Harvard College |
Armazones tridimensionales macroscópicos preformados inyectables para administración mínimamente invasiva
|
|
US9675561B2
(en)
|
2011-04-28 |
2017-06-13 |
President And Fellows Of Harvard College |
Injectable cryogel vaccine devices and methods of use thereof
|
|
CN103842374A
(zh)
|
2011-05-13 |
2014-06-04 |
诺华股份有限公司 |
融合前的rsv f抗原
|
|
AU2012261848B2
(en)
|
2011-06-03 |
2017-06-15 |
President And Fellows Of Harvard College |
In situ antigen-generating cancer vaccine
|
|
ES2395677B1
(es)
*
|
2011-07-29 |
2013-12-26 |
Instituto De Salud Carlos Iii |
Proteína F del VRSH en conformación pre-fusión estabilizada y anticuerpos neutralizantes específicos frente a la misma.
|
|
EP2752199A4
(en)
|
2011-08-29 |
2015-04-29 |
Univ Tokushima |
RSV MUCOSA VACCINE
|
|
SG10201602434UA
(en)
*
|
2011-09-30 |
2016-05-30 |
Novavax Inc |
Recombinant nanoparticle rsv f vaccine for respiratory syncytial virus
|
|
CA2870182A1
(en)
*
|
2012-04-10 |
2013-10-17 |
The Trustees Of The University Of Pennsylvania |
Human respiratory syncytial virus consensus antigens, nucleic acid constructs and vaccines made therefrom, and methods of using same
|
|
PT2838515T
(pt)
|
2012-04-16 |
2020-02-25 |
Harvard College |
Composições de sílica mesoporosa para modular respostas imunológicas
|
|
EA201891945A3
(ru)
*
|
2012-08-01 |
2019-05-31 |
Бавариан Нордик А/С |
Вакцина рекомбинантного модифицированного вируса осповакцины анкара (mva) респираторно-синцитиального вируса (rsv)
|
|
PT2879702T
(pt)
*
|
2012-08-01 |
2020-02-04 |
Bavarian Nordic As |
Vacina para o vírus sincicial respiratório (rsv) de vírus vaccinia modificado recombinante ankara (mva)
|
|
US20140037680A1
(en)
|
2012-08-06 |
2014-02-06 |
Glaxosmithkline Biologicals, S.A. |
Novel method
|
|
SG11201500573RA
(en)
|
2012-08-06 |
2015-02-27 |
Glaxosmithkline Biolog Sa |
Method for eliciting in infants an immune response against rsv and b. pertussis
|
|
KR20150138184A
(ko)
*
|
2013-02-11 |
2015-12-09 |
노바백스, 인코포레이티드 |
호흡기 세포 융합 바이러스 및 인플루엔자를 위한 조합 백신
|
|
AU2014304545A1
(en)
|
2013-08-05 |
2016-02-25 |
Glaxosmithkline Biologicals S.A. |
Combination immunogenic compositions
|
|
EP3137105A4
(en)
|
2014-04-30 |
2017-12-27 |
President and Fellows of Harvard College |
Combination vaccine devices and methods of killing cancer cells
|
|
US11571472B2
(en)
|
2014-06-13 |
2023-02-07 |
Glaxosmithkline Biologicals Sa |
Immunogenic combinations
|
|
HK1247861A1
(zh)
|
2015-01-30 |
2018-10-05 |
President And Fellows Of Harvard College |
用於癌症治疗的肿瘤周围和肿瘤内部材料
|
|
CN114099793A
(zh)
|
2015-04-10 |
2022-03-01 |
哈佛学院院长等 |
免疫细胞捕获装置及其制备和使用方法
|
|
IL257800B2
(en)
|
2015-09-03 |
2023-11-01 |
Novavax Inc |
Immune compositions with improved stability and immunogenicity
|
|
PE20240817A1
(es)
|
2015-12-23 |
2024-04-18 |
Pfizer |
Mutantes de proteina f de rsv
|
|
CN115487351A
(zh)
|
2016-02-06 |
2022-12-20 |
哈佛学院校长同事会 |
重塑造血巢以重建免疫
|
|
EP3484448B1
(en)
|
2016-07-13 |
2025-04-09 |
President and Fellows of Harvard College |
Antigen-presenting cell-mimetic scaffolds and methods for making and using the same
|
|
RU2770060C2
(ru)
|
2016-08-02 |
2022-04-14 |
Президент Энд Феллоуз Оф Гарвард Колледж |
Биологические материалы для модуляции иммунных ответов
|
|
WO2018026941A1
(en)
|
2016-08-03 |
2018-02-08 |
Lonza Walkersville, Inc. |
Method of detecting an endotoxin using limulus amebocyte lysate substantially free of coagulogen
|
|
GB201620968D0
(en)
|
2016-12-09 |
2017-01-25 |
Glaxosmithkline Biologicals Sa |
Adenovirus polynucleotides and polypeptides
|
|
CN110192110B
(zh)
*
|
2017-01-11 |
2023-01-10 |
隆萨沃克斯维尔股份有限公司 |
无凝固蛋白原的澄清的鲎阿米巴样细胞裂解物
|
|
US12083228B2
(en)
|
2017-07-24 |
2024-09-10 |
Novavax, Inc. |
Methods and compositions for treating respiratory disease
|
|
EP3697902A1
(en)
|
2017-10-16 |
2020-08-26 |
GlaxoSmithKline Biologicals S.A. |
Enhanced promoter
|
|
CA3084346A1
(en)
|
2017-10-16 |
2019-04-25 |
Glaxosmithkline Biologicals Sa |
Simian adenoviral vectors with two expression cassettes
|
|
CA3079048A1
(en)
|
2017-10-16 |
2019-04-25 |
Glaxosmithkline Biologicals Sa |
Adenoviral vectors with two expression cassettes encoding rsv antigenic proteins or fragments thereof
|
|
US11905313B2
(en)
|
2017-11-28 |
2024-02-20 |
The United States of America, as represented by the Secretary, Department of Health and Human Services. |
Recombinant RSV G proteins and their use
|
|
AU2019238171B2
(en)
|
2018-03-19 |
2026-01-08 |
Novavax, Inc. |
Multivalent influenza nanoparticle vaccines
|
|
CN112638936A
(zh)
|
2018-06-12 |
2021-04-09 |
葛兰素史密丝克莱恩生物有限公司 |
腺病毒多核苷酸和多肽
|
|
WO2020061129A1
(en)
|
2018-09-19 |
2020-03-26 |
President And Fellows Of Harvard College |
Compositions and methods for labeling and modulation of cells in vitro and in vivo
|
|
KR102725189B1
(ko)
|
2018-11-01 |
2024-10-31 |
에스케이바이오사이언스(주) |
재조합 호흡기 세포융합 바이러스 f 단백질 및 이를 포함하는 백신 조성물
|
|
AU2020227545B2
(en)
|
2019-02-28 |
2023-10-19 |
Km Biologics Co., Ltd. |
RSV F/G chimeric vaccine
|
|
EP4034148A4
(en)
|
2019-09-23 |
2025-09-10 |
Harvard College |
BIOMATERIAL-BASED ANTIGEN-FREE VACCINE AND ITS USE
|
|
CN114993784B
(zh)
*
|
2022-05-27 |
2025-07-29 |
重庆医科大学 |
一种乙肝病毒颗粒裂解液及其制备与应用
|
|
WO2025263563A1
(ja)
*
|
2024-06-20 |
2025-12-26 |
Ｋｍバイオロジクス株式会社 |
ＲＳＶ ＦＧキメラｍＲＮＡワクチン
|